You are here: Industry Insights > LabCorp

News List

Labcorp, QIAGEN announce companion diagnostic for metastatic breast cancer biospectrumasia
June 10, 2019
Piqray, in combination with fulvestrant, and therascreen PIK3CA PCR mutation analysis assay received approval from the U.S. Food and Drug Administration (FDA) on May 24, 2019.
LabCorp snaps up Envigo's nonclinical business fiercebiotech
April 28, 2019
LabCorp’s CRO business Covance will boost its nonclinical contract research services business as its parent company buys out the segment from Envigo, while the latter repositions.
LabCorp and Envigo Sign Innovative Agreement to Expand Covance’s Nonclinical Drug Development Capabilities and Create an Independent Research Models Provider pharmafocusasia
April 19, 2019
LabCorp and Envigo Sign Innovative Agreement to Expand Covance’s Nonclinical Drug Development Capabilities and Create an Independent Research Models Provider
LabCorp, Quest Face a More Difficult 2018 After Continued M&A Expansion biospace
January 02, 2018
Over the years, the two largest commercial clinical diagnostic laboratory companies in the U.S., and probably the world, have been Laboratory Corporation of America known as LabCorp,and Quest Diagnostics. For years,
LabCorp completes acquisition of Chiltern for $1.2bn pharmaceufical-technology
September 05, 2017
US-based global life sciences company LabCorp has completed the acquisition of Chiltern, a specialist contract research organisation (CRO), for approximately $1.2bn.
LabCorp to acquire Chiltern for $1.2 billion in cash biospectrumasia
August 04, 2017
Chiltern is a leading CRO among emerging-to-mid biopharma customers, with forecasted 2017 revenue and adjusted EBITDA of approximately $550 million and $95 million, respectively, and backlog of approximately $1.0 billion.
LabCorp to buy Chiltern for approximately $1.2bn pharmaceutical-technology
August 02, 2017
US-based global life sciences company LabCorp is set to acquire Chiltern, a specialist contract research organisation (CRO), in an all-cash transaction valued at approximately $1.2bn.

Previous page 1 2 Next page